Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-005537
Filing Date
2025-02-21
Accepted
2025-02-21 21:05:26
Documents
2
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5940
2 EXHIBIT 24 ef20044143_ex24.htm EX-24 7244
  Complete submission text file 0001140361-25-005537.txt   14783
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Issuer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address
FINGER ALISON CECILY (Reporting) CIK: 0001731164 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36728 | Film No.: 25653943